ATERO : A Randomised Study With Tranexamic Acid in Epistaxis of Rendu Osler Syndrome

NCT00355108 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

170

Enrollment

OTHER

Sponsor class

Conditions

Telangiectasia, Hereditary Hemorrhagic
Osler-Rendu Disease

Interventions

DRUG: tranexamic acid

Sponsor

Hospices Civils de Lyon